Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA-8159, an erectogenic, in rats.

Source:http://linkedlifedata.com/resource/pubmed/id/17351661

Download in:

View as

General Info

PMID
17351661